Author: Vitale, Samantha; Foss, Kari
Title: Immune-Mediated Central Nervous System Disease—Current Knowledge and Recommendations Cord-id: u9d2yaz2 Document date: 2018_12_4
ID: u9d2yaz2
Snippet: Immune-mediated inflammation is responsible for about 25% of central nervous system disease in dogs. The disease can affect all ages and breeds, but young to middle-aged small breed dogs are over-represented for most forms. Diagnosis consists of advanced imaging (MRI), cerebrospinal fluid analysis, and infectious disease testing, but biopsy is required for definitive diagnosis and classification of the disease into one of the many subtypes. Treatment consists of immunosuppressive medication with
Document: Immune-mediated inflammation is responsible for about 25% of central nervous system disease in dogs. The disease can affect all ages and breeds, but young to middle-aged small breed dogs are over-represented for most forms. Diagnosis consists of advanced imaging (MRI), cerebrospinal fluid analysis, and infectious disease testing, but biopsy is required for definitive diagnosis and classification of the disease into one of the many subtypes. Treatment consists of immunosuppressive medication with the goal being to control and/or improve clinical signs. Current literature shows that prognosis is variable.
Search related documents:
Co phrase search for related documents- abdominal imaging and additional information: 1
- acid glycoprotein and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acid glycoprotein and acute phase protein: 1, 2, 3, 4, 5, 6, 7, 8
- acid protein and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acid protein and acute phase protein: 1, 2, 3, 4, 5, 6, 7
- acid protein and additional information: 1, 2
- acute phase and additional information: 1
- acute phase and adjunctive therapy: 1
Co phrase search for related documents, hyperlinks ordered by date